The study found that MS patients had 50% less amyloid plaque accumulation, a key indicator of Alzheimer’s, compared to non-MS individuals. This connection between MS and reduced Alzheimer’s risk highlights potential immune-related mechanisms that may be leveraged for therapeutic strategies.
Key Facts:
- MS patients are 50% less likely to develop amyloid plaques, a hallmark of Alzheimer’s.
- The immune response in MS might help reduce amyloid buildup in the brain.
- This discovery opens up new avenues for Alzheimer’s research and potential treatments.
6 points
That’s an unfortunate “Would you rather…”. Hopefully the research pans out though, could be good news for both groups if their lucky.
